On Tuesday, AstraZeneca plc (ADR) (NYSE:AZN)’s shares inclined 3.91% to $32.94.
Data will be stated from across AstraZeneca’s industry-leading lung cancer portfolio at the World Conference on Lung Cancer (WCLC) 2015, starting this weekend in Denver, Colorado. Presentations will feature 25 abstracts (counting 9 oral and 4 late breaker presentations) on the company’s lung cancer pipeline, designed to address the unmet needs of patients with different forms of lung cancer.
AZD9291 (osimertinib)1: Targeting resistance mechanisms in lung cancer
AZD9291 will be the focus of six oral presentations on its clinical activity in both first-line and formerly-treated patients with epidermal growth factor receptor mutation (EGFRm) T790M advanced non-small cell lung cancer (NSCLC). The data are compriseent with formerly stated efficacy and safety results of AZD9291 in these treatment settings.
Antoine Yver, Head of Oncology, Global Medicines Development at AstraZeneca said: “The data presented at WCLC illustrate the breadth of our lung cancer research across multiple disease settings and lines of therapy, as we aim to develop a comprehensive portfolio of effective and durable treatments for patients. AZD9291 is moving through clinical development with unprecedented speed, and was recently granted US Precedingity Review designation in recognition of its potential to target the mutation that drives resistance to current treatments for EGFR mutation positive advanced non-small cell lung cancer in the majority of patients.”
In addition to AZD9291, AstraZeneca will also present results from the IRESSA® (gefitinib) Clinical Access Program (ICAP), which provides data on the long-term safety and tolerability of the EGFR tyrosine kinase inhibitor in 188 US cancer patients outside the clinical trial setting. IRESSA® was approved by the US Food and Drug Administration (FDA) in July 2015, and is already accessible in 91 countries worldwide.
AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection, and neuroscience diseases worldwide. Its products comprise Crestor for the treatment of dyslipidaemia and hypercholesterolemia; Seloken/Toprol-XL to control hypertension, and heart failure and angina; Onglyza for diabetes mellitus; Iressa for non-small cell lung cancer; Faslodex for breast cancer in post-menopausal women; Zoladex for prostate cancer, breast cancer, and certain benign gynaecological disorders; Pulmicort Turbuhaler/Pulmicort Flexhaler for treating asthma; Symbicort for maintenance treatment of asthma and chronic obstructive pulmonary disease; Nexium for treatment of acid-related diseases; Seroquel XR for the treatment of schizophrenia, bipolar disorder, major depressive disorder, and generalised anxiety disorder; and Synagis for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus in paediatric patients.
FreeSeas Inc (NASDAQ:FREE)’s shares dropped -0.60% to $0.330.
FreeSeas Inc (FREE) through the ownership and operation of a fleet of Handysize vessels declared recently that it has attained a 51% controlling stake in the newly formed Standcorp International Limited. The rest of the shares are owned by non-associated entities associated with the Marvin group of companies, whose extensive experience for over twenty years has focused in the operation and ownership of tanker vessels. Standcorp will engage in the commercial operation of product and crude oil tankers covering a large array of sizes, by contracting them through time charter or bareboat charter arrangements, and subsequently deploying them in the spot market or in fulfillment of contract cargoes. The company intends to operate in generic markets but also to focus on a number of niche markets, such as West Africa. In addition, the company shall, depending on market conditions, commercially operate dry-bulk carriers either chartered-in, attained, or through services agreements with associated Owners, counting FreeSeas Inc. tonnage.
FreeSeas Inc., through its auxiliaries, provides drybulk shipping services. Its vessels carry various drybulk commodities, such as iron ore, grain, and coal, in addition to bauxite, phosphate, fertilizers, steel products, cement, sugar, and rice. Its fleet comprises of five Handysize vessels and one Handymax vessel. As of April 23, 2015, its operational fleet had about 148,978 deadweight tons with the average age of 17.7 years
At the end of Tuesday’s trade, Western Digital Corp(NASDAQ:WDC)‘s shares surged 4.85% to $83.90.
WD®, a Western Digital (WDC) company, and a worldwide leader in storage solutions, introduced noteworthyenhancements to WD’s family of My Cloud® personal storage devices, counting a new, redesigned My Cloud OS 3 operating system, Software Developer Kit (SDK) enabling improved app integration and a dual-drive My Cloud Mirror personal cloud storage offering raised memory and faster processing performance than previous generations.
WD’s My Cloud OS 3 features an intuitive user interface delivering a rich content-sharing experience, and back-up and sync capabilities that elevate the personal cloud NAS offering while retaining the privacy and control unique to personal cloud devices physically located in the home or office.
My Cloud OS 3 features powerful new photo and video capabilities via two new user experiences: MyCloud.com and My Cloud Albums app. MyCloud.com provides users global access to their My Cloud via an intuitive web browser-based user interface and enables file collaboration, comprehensive access administration and a photos and videos gallery view. My Cloud Albums, accessible for download late September on iTunes and Google Play stores, allows a My Cloud OS 3 user to send a link to a common location, or “album”, on the My Cloud to all their friends and family.
Western Digital Corporation, together with its auxiliaries, engages in the development, manufacture, sale, and provision of data storage solutions that enable consumers, businesses, governments, and other organizations to create, manage, experience, and preserve digital content worldwide. The company’s product portfolio comprises hard disk drives (HDDs), solid-state drives (SSDs), direct attached storage solutions, personal cloud network attached storage solutions, and public and private cloud data center storage solutions.
Marriott International Inc(NASDAQ:MAR), ended its Tuesday’s trading session with 3.43% gain, and closed at $72.42.
Marriott International’s award winning #LoveTravels campaign is launching a new portrait and video series featuring recognized Latino influencers Diane Guerrero (OITNB, Jane the Virgin), Diego Boneta (Scream Queens), and Boyce Avenue (YouTube music sensation). #LoveTravels encourages all travelers to explore their personal passions, and celebrate their unique perspectives and experiences.
The stories from the new #LoveTravels ambassadors reflect how travel is a transformative experience and a bridge between cultures, careers and families. Diego, Diane and Boyce Avenue, who are deeply proud of their heritage, talk about what it means for them to be Latino and American, their passion for human rights and the empowerment of the Latino community.
Marriott International, Inc. operates franchises, and licenses hotels and timeshare properties worldwide. It operates through three segments: North American Full-Service, North American Limited-Service, and International. The company also licenses the development, operation, marketing, sale, and administration of vacation ownership and related products under the Marriott Vacation Club, Grand Residences by Marriott, The Ritz-Carlton Destination Club, and The Ritz-Carlton Residences brands to the Marriott Vacations Worldwide Corporation.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
